FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002621 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Dongmei Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, …. Hauptthemen laut MEDLINE: Cholesterol, Adenocarcinoma of Lung, Lung Neoplasms, Hepatocyte Nuclear Factor 3-gamma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Chongqing, China.
Abstract (Originalsprache)
Cholesterol metabolism is vital for multiple cancer progression, while how cholesterol affects lung, a low-cholesterol tissue, for cancer metastasis and the underlying mechanism remain unclear. In this study, we found that metastatic lung adenocarcinoma cells acquire cellular dehydrocholesterol and cholesterol by endogenous cholesterol biosynthesis, instead of uptake upon cholesterol treatment. Besides, we demonstrated that exogenous cholesterol functions as signaling molecule to induce FOXA3, a key transcription factor for lipid metabolism via GLI2. Subsequently, ChIP-seq analysis and molecular studies revealed that FOXA3 transcriptionally activated Hmgcs1, an essential enzyme of cholesterol biosynthesis, to induce endogenous dehydrocholesterol and cholesterol level for membrane composition change and cell migration. Conversely, FOXA3 knockdown or knockout blocked cholesterol biosynthesis and lung adenocarcinoma metastasis in mice. In addition, the potent FOXA3 inhibitor magnolol suppressed metastatic gene programs in lung adenocarcinoma patient-derived organoids (PDOs). Altogether, our findings shed light onto unique cholesterol metabolism and FOXA3 contribution to lung adenocarcinoma metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
- Department of Gastrointestinal Surgery, the Affiliated Changzhou, No. 2 People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, China.
- Institute of Organoid Technology, BioGenous Biotechnology, Inc., Suzhou, China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- Joint Center for Translational Medicine, Fengxian District Central Hospital, Fengxian District, Shanghai, China.
- Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
ORCID-Profile: Xinran Ma
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing, China
- Natural Science Foundation of Shanghai
- The Innovative Research Team of High-level Local Universities in Shanghai
- National Key Research and Development Program of China.
- the Clinical Research Plan of SHDC
Zitieren
APA
Wang, D., Cao, Y., Meng, M., Qiu, J., Ni, C., Guo, X., Li, Y., Liu, S., Yu, J., Guo, M., Wang, J., Du, B., Qiu, W., Xie, C., Zhao, B., Ma, X., Cheng, X., & Xu, L. (2024). FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002621
Vancouver
Wang D, Cao Y, Meng M, Qiu J, Ni C, Guo X, et al. FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002621
BibTeX
@article{Wang2024,
author = {Wang, Dongmei and Cao, Yuxiang and Meng, Meiyao and Qiu, Jin and Ni, Chao and Guo, Xiaozhen and Li, Yu and Liu, Shuang and Yu, Jian and Guo, Mingwei and Wang, Jiawen and Du, Bing and Qiu, Wenwei and Xie, Cen and Zhao, Bing and Ma, Xinran and Cheng, Xinghua and Xu, Lingyan},
title = {FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002621}
}
EUVIMED